| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,133 |
9,433 |
$685K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,491 |
7,427 |
$456K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,358 |
4,325 |
$402K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,797 |
4,609 |
$247K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,324 |
1,293 |
$51K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,743 |
1,707 |
$21K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
848 |
817 |
$21K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,434 |
722 |
$17K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
597 |
588 |
$14K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
264 |
264 |
$11K |
| 99000 |
|
4,538 |
4,376 |
$9K |
| 81025 |
|
1,111 |
1,093 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
796 |
755 |
$7K |
| 81003 |
|
2,961 |
2,898 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
71 |
70 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
869 |
846 |
$3K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
320 |
313 |
$3K |
| 87428 |
|
34 |
34 |
$717.36 |
| 90756 |
|
41 |
39 |
$586.52 |
| 73610 |
|
15 |
15 |
$304.47 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
36 |
35 |
$295.30 |
| 90674 |
|
15 |
15 |
$253.17 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
47 |
46 |
$32.18 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
29 |
28 |
$27.65 |
| 99051 |
|
319 |
312 |
$21.26 |
| 99072 |
|
1,987 |
1,912 |
$4.50 |
| G8484 |
Influenza immunization was not administered, reason not given |
818 |
760 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
292 |
276 |
$0.00 |